US$30 million (~A$48 million) upfront payment (a large, immediate capital injection).
Up to US$560 million (~A$892 million) in success-based milestone payments, broken down as:
US$75M pre-approval (based on trial success and FDA approval),
US$35M on first U.S. commercial sale,
US$410M in commercial milestones, and
US$40M for other indications.
Tiered royalties from low teens to low twenties % on U.S. net sales.
WOW WOW WOW HUGE HUGE HUGE STELLAR STELLAR
Massive upside potential from nearly A$900 million in milestones + royalties.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
50.5¢ |
Change
-0.005(0.98%) |
Mkt cap ! $297.1M | |||
| Open | High | Low | Value | Volume |
| 51.0¢ | 53.5¢ | 50.0¢ | $908.3K | 1.780M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23499 | 50.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.5¢ | 19076 | 2 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| DXB (ASX) Chart |